http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201709906-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3b86b422fd86877ea8b63805f55aeea3
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-10
filingDate 2015-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_432493fdfa8922cacebda1ae399d24f9
publicationDate 2017-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-201709906-A
titleOfInvention Use of selected anticholinergic zwitterions
abstract Selected anti-cholinergic zwitterions are administered to slow the progression of myopia in children and generally treat myopia.
priorityDate 2015-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415887596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452826178
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID228404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4848
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10352272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453416683
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25514
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID174174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413311232
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1117

Total number of triples: 27.